Eradication of metastatic renal cell carcinoma after adenovirus-encoded TNF-related apoptosis-inducing ligand (TRAIL)/CpG immunotherapy
Lyse A. Norian, Timothy P. Kresowik, Henry M. Rosevear, Britnie R. James, Timothy R. Rosean, Andrew J. Lightfoot, Tamara A Kucaba, Christopher Schwarz, Christine J. Weydert, Michael D. Henry, Thomas S. Griffith
Dive into the research topics of 'Eradication of metastatic renal cell carcinoma after adenovirus-encoded TNF-related apoptosis-inducing ligand (TRAIL)/CpG immunotherapy'. Together they form a unique fingerprint.